Efficacy of mepolizumab in usual clinical practice and characteristics of responders-Reference-Cited by-同舟云学术

Efficacy of mepolizumab in usual clinical practice and characteristics of responders

Published:2021-10 Issue: Volume:187 Page:106595
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Rodríguez-García Carlota,Blanco-Aparicio Marina,Nieto-Fontarigo Juan José,Blanco-Cid Nagore,Gonzalez-Fernandez Coral,Mosteiro-Añon Mar,Calvo-Alvarez Uxío,Perez-De-Llano Luis,Corbacho-Abelaira María Dolores,Lourido-Cebreiro Tamara,Dominguez-Juncal Luis Miguel,Crespo-Diz Carlos,Dacal-Quintas Raquel,Pallares-Sanmartin Abel,Dacal-Rivas David,Gonzalez-Barcala Francisco Javier

Funder

Sociedad Española de Neumología y Cirugía Torácica

GlaxoSmithKline

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference26 articles.

1. One year of mepolizumab. Efficacy and safety in real-life in Italy;Bagnasco;Pulm. Pharmacol. Ther.,2019

2. Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data;Renner;Pulm. Pharmacol. Ther.,2020

3. Characteristics and prognosis of near-fatal asthma exacerbations;Gonzalez-Barcala;Am. J. Med. Sci.,2015